Glenview Capital Management 13F, Q2 2023

Larry Robbins · quarter ending 30 June 2023 · filed 14 August 2023 · SEC CIK 1138995

$3.72B
Filed US book
46
Positions
15.6%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed. The filing also lists 3 put and call lines, reported at the value of the underlying shares; they are not ownership and are not in these totals.

Largest positions, Q2 2023

The 25 largest of 46 positions. Weights are against the whole filed book.

CompanyTickerValue% of book
THE CIGNA GROUPCI$579.59M15.6%
TENET HEALTHCARE CORPTHC$526.43M14.1%
DXC TECHNOLOGY CODXC$260.10M7.0%
UNIVERSAL HLTH SVCS INCUHS$222.54M6.0%
GLOBAL PMTS INCGPN$221.10M5.9%
CLARIVATE PLC$165.02M4.4%
MCKESSON CORPMCK$161.61M4.3%
ALIGHT INCALITEUR$139.50M3.8%
CORTEVA INCCTVA$119.94M3.2%
US FOODS HLDG CORPUSFD$112.35M3.0%
FISERV INCFISV$111.15M3.0%
VALVOLINE INCVVV$105.12M2.8%
FMC CORPFMC$88.92M2.4%
MYRIAD GENETICS INCMYGN$86.81M2.3%
APTIV PLC$84.52M2.3%
HCA HEALTHCARE INCHCA$80.00M2.1%
BROOKDALE SR LIVING INCBKD$78.68M2.1%
DUPONT DE NEMOURS INCDWDPEUR$74.45M2.0%
UBER TECHNOLOGIES INCUBER$67.26M1.8%
ACTIVISION BLIZZARD INCATVIEUR$57.65M1.6%
ELEMENT SOLUTIONS INCESI$48.90M1.3%
EXPEDIA GROUP INCEXPE$41.90M1.1%
EVOLV TECHNOLOGIES HLDNGS INEVLV$28.98M0.8%
CARDINAL HEALTH INCCAH$24.34M0.7%
FEDEX CORPFDX$23.71M0.6%

This is the earliest Glenview Capital Management 13F we hold, so there is no earlier filing here to compare it with.

Other quarters

Source: SEC Form 13F-HR, accession 0000905148-23-000724, filed by GLENVIEW CAPITAL MANAGEMENT, LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.